The cost of Stelara without insurance can vary significantly based on factors such as dosage, quantity, and pharmacy. However, without insurance, a month's supply can range from approximately $6,500 to over $10,000 [1].
How can I get financial assistance for Stelara?
For those without insurance, several patient assistance programs may help reduce the out-of-pocket cost of Stelara. The manufacturer, Janssen (a Johnson & Johnson company), offers programs like the Janssen CarePath Savings Program for eligible commercially insured patients and may provide assistance for uninsured individuals [2]. Eligibility for these programs typically depends on income and insurance status [1][2].
What is the typical dosage and frequency for Stelara?
Stelara is administered as an injection. Initial dosing for conditions like plaque psoriasis or psoriatic arthritis involves an induction dose, followed by maintenance doses [3]. For plaque psoriasis, it is typically given every 12 weeks after the initial doses [3]. For Crohn's disease and ulcerative colitis, it is administered every 8 weeks after the initial infusion [3].
How does Stelara work?
Stelara (ustekinumab) is a medication that works by targeting specific proteins in the body. It is an interleukin inhibitor, specifically targeting IL-12 and IL-23, which are believed to play a role in inflammatory diseases [3]. By blocking these interleukins, Stelara helps to reduce inflammation associated with certain autoimmune conditions [3].
When does the patent for Stelara expire?
The primary patents protecting Stelara have faced various challenges. For example, a key patent related to its use for plaque psoriasis was invalidated in Delaware in 2021 [4]. However, other patents may still be in effect, and the exact expiration dates and patent landscape can be complex, often involving ongoing litigation [4]. Information on patent expiry and related litigation can be found on sites like DrugPatentWatch.com [5].
What are the approved uses for Stelara?
Stelara is approved for the treatment of several moderate to severe autoimmune conditions. These include plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis [3].
What are potential side effects of Stelara?
Common side effects associated with Stelara include upper respiratory infections, headache, fatigue, dizziness, and injection site reactions [3]. More serious risks can include an increased risk of infections, allergic reactions, and certain types of cancer [3]. Patients should discuss all potential risks and benefits with their healthcare provider.
Are there alternative treatments for conditions treated by Stelara?
Yes, there are alternative treatments available for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. These can include other biologic medications that target different inflammatory pathways, as well as non-biologic systemic therapies and topical treatments [3]. The choice of alternative depends on the specific condition, its severity, and individual patient factors.
Can biosimilars of Stelara be developed?
The development of biosimilars for Stelara is possible once the relevant patents expire and exclusivity periods end. Biosimilars are highly similar to the original biologic drug and are approved by regulatory agencies based on a demonstration of no clinically meaningful differences [6]. The timeline for biosimilar entry is influenced by patent litigation and regulatory approval processes.
---
Sources:
[1] GoodRx. (n.d.). Stelara Prices, Coupons & Patient Assistance Programs. Retrieved from https://www.goodrx.com/stelara
[2] Janssen Biotech, Inc. (n.d.). Janssen CarePath. Retrieved from https://www.janssen.com/patients/carepath
[3] National Library of Medicine. (n.d.). Ustekinumab. Retrieved from https://medlineplus.gov/druginfo/meds/a607039.html
[4] Freeney, J. (2021, February 24). J&J Loses Patent Fight Over Stelara Blockbuster. Law360.
[5] DrugPatentWatch. (n.d.). Stelara Patent Expiry. Retrieved from https://drugpatentwatch.com/
[6] U.S. Food & Drug Administration. (n.d.). Biosimilar Product Information. Retrieved from https://www.fda.gov/drugs/biosimilars/biosimilar-product-information